Reuters logo
BRIEF-Corbus Pharmaceuticals announces $27.2 mln registered direct offering
February 28, 2017 / 2:10 PM / in 9 months

BRIEF-Corbus Pharmaceuticals announces $27.2 mln registered direct offering

Feb 28 (Reuters) - Corbus Pharmaceuticals Holdings Inc

* Corbus Pharmaceuticals announces $27.2 million registered direct offering

* Corbus Pharmaceuticals Holdings Inc says company is selling 3.9 million shares at a purchase price of $7.00 per share Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below